Techniques to treat neurological disorders by attenuating the production of pro-inflammatory mediators

Details for Australian Patent Application No. 2004283720 (hide)

Owner Medtronic, Inc.

Inventors Shafer, Lisa L.

Agent Spruson & Ferguson

Pub. Number AU-A-2004283720

PCT Pub. Number WO2005/039393

Priority 60/514,137 24.10.03 US

Filing date 22 October 2004

Wipo publication date 6 May 2005

International Classifications

A61K 38/20 (2006.01) Medicinal preparations containing peptides - Interleukins

Event Publications

1 June 2006 PCT application entered the National Phase

  PCT publication WO2005/039393 Priority application(s): WO2005/039393

26 May 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004283721-Rapidly disintegrating film

2004283717-Methods of treating cancer with HDAC inhibitors